Airway colonisation and postoperative pulmonary complications after neoadjuvant therapy for oesophageal cancer
Home » Airway colonisation and postoperative pulmonary complications after neoadjuvant therapy for oesophageal cancer ... Airway colonisation and postoperative pulmonary complications after neoadjuvant therapy for oesophageal cancer. ... Airway colonisation by PPMs after neoadjuvant therapy is suggested as a possible cause of postoperative ARDS after ... Pre-emptive therapy was administrated in seven patients: four antiviral and three antibiotic prophylaxes. Postoperatively, 14 ...http://connection.ebscohost.com/c/articles/30018615/airway-colonisation-postoperative-pulmonary-complications-after-neoadjuvant-therapy-oesophageal-cancer
Chapter 85. Neoadjuvant Chemotherapy | Kuerer's Breast Surgical Oncology | AccessSurgery | McGraw-Hill Medical
Thus neoadjuvant systemic therapy can be used as an in vivo assay of systemic therapy efficacy. This, in theory, can allow for ... Indeed, this was shown in a study by Boughey et al3 in which patients treated with neoadjuvant therapy were compared with ... Another rationale for neoadjuvant systemic therapy is that this allows for the immediate treatment of micrometastases; however ... Neoadjuvant Chemotherapy. In: Kuerer HM. Kuerer H.M. Ed. Henry M. Kuerer.eds. Kuerer's Breast Surgical Oncology New York, NY: ...http://accesssurgery.mhmedical.com/content.aspx?bookid=428§ionid=39936217
Perioperative Therapy for Resectable Pancreatic Cancer - Full Text View - ClinicalTrials.gov
NEOADJUVANT CHEMORADIOTHERAPY: Beginning no more than 14 days after completion of induction chemotherapy, patients receive ... Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy, such as IMRT, that delivers a ... Perioperative Therapy for Resectable Pancreatic Cancer. The safety and scientific validity of this study is the responsibility ... Clinical Response Rate to Neoadjuvant Chemotherapy and Chemoradiotherapy [ Time Frame: Up to 7 years ]. Assessed using the new ...https://clinicaltrials.gov/show/NCT00609336
Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label...
Velenik V, Oblak I, Anderluh F: Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for ... Willett CG, Boucher Y, Duda DG, di Tomaso E, Munn LL, et al.: Surrogate markers for antiangiogenic therapy and dose-limiting ... Crane CH, Eng C, Feig BW, Das P, Skibber JM, et al.: Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy ... Nogue M, Salud A, Vincente P, Arrivi A, Roca JM, et al.: Addition of bevacizumab to XELOX induction therapy plus concomitant ...http://ro-journal.biomedcentral.com.preview-live.oscarjournals.springer.com/articles/10.1186/1748-717X-6-105
MicroRNA-330-5p as a putative modulator of neoadjuvant chemoradiotherapy sensitivity in oesophageal adenocarcinoma
... combined neoadjuvant chemoradiation therapy (neo-CRT) prior to surgery. Unfortunately, ~60-70% of patients will fail to respond ... Bibby B.A.S, Reynolds J.V, Maher S.G, MicroRNA-330-5p as a putative modulator of neoadjuvant chemoradiotherapy sensitivity in ... MicroRNA-330-5p as a putative modulator of neoadjuvant chemoradiotherapy sensitivity in oesophageal adenocarcinoma. ... The standard of care for locally advanced disease is neoadjuvant chemotherapy or, more commonly, ...http://www.tara.tcd.ie/handle/2262/79636
Neoadjuvant therapy for patients with borderline resectable pancreatic cancer: A systematic review and meta-analysis of...
CONCLUSIONS The resection and R0 resection rates in the group of borderline resectable tumor patients after neoadjuvant therapy ... The survival estimates of borderline resectable tumor patients after neoadjuvant therapy were similar to resectable tumor ... How to find chemo-responsiveness before neoadjuvant chemotherapy so as to give individualized treatment is still an important ... Patients with borderline resectable pancreatic cancer should be included in neoadjuvant protocols and subsequently be ...https://www.semanticscholar.org/paper/Neoadjuvant-therapy-for-patients-with-borderline-r-Tang-Lu/107d83217354a82cba85cb410cc5fa9357c35c9f
Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma - Full Text...
Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma. The safety ... A Pilot and Phase II Study of Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III ... Capecitabine will be delivered concurrently with the radiation therapy, at a dose of 1650 mg/m2 divided in even BID doses. It ... The proposed protocol aims to continue tumor-directed therapy during the typical 'break period' in an effort to improve on both ...https://clinicaltrials.gov/ct2/show/NCT01302613
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast...
As part of this effort, data published to date were critically reviewed and indications for neoadjuvant treatment were newly ... recommendations published in 2006 regarding neoadjuvant treatment for operable disease required updating. Therefore, a third ... Neoadjuvant (primary systemic) treatment has become a standard option for primary operable disease for patients who are ... Antineoplastic Agents, Breast Neoplasms, Chemotherapy, Adjuvant, Combined Modality Therapy, Gene Expression Profiling, Humans, ...https://www.ndph.ox.ac.uk/publications/265311
Tags: neoadjuvant therapy, News, non-metastatic, Pancreatic Cancer, radiation, Stages I-III Pancreatic Cancer ... Radiation Therapy for Prostate Cancer *Techniques for Delivering Radiation Therapy Prostate. *What to Expect During Radiation ... Chemotherapy administered before surgery is called neoadjuvant therapy and has not previously been demonstrated to improve ... neoadjuvant therapy, News, Sarcoma, soft tissue sarcoma ... Radiation Therapy for Breast Cancer. *Hormonal Therapy for ...http://cancer.unm.edu/tag/neoadjuvant-therapy/
Safety and Efficacy Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy as Neoadjuvant Treatment for Participants...
Has a diagnosis of immunodeficiency or is receiving systemic steroid therapy or any other form of immunosuppressive therapy ... Has received prior chemotherapy, targeted therapy, radiation therapy, immunotherapy that targets immune checkpoints, co- ... Is currently participating and receiving study therapy, or has participated in a study of an investigational agent and received ... Has an active infection requiring systemic therapy.. *Has significant cardiovascular disease, such as: History of myocardial ...https://clinicaltrials.gov/ct2/show/NCT02622074
Radiation No Extra Benefit To Stage IIIA/N2 NSCLC Neoadjuvant Chemotherapy | OncologyPRO
Neoadjuvant chemoradiotherapy does not offer greater survival for stage IIIA/N2 non-small-cell lung cancer patients than ... Topic: Anti-Cancer Agents & Biologic Therapy / Non-Small-Cell Lung Cancer, Locally Advanced / Surgery and/or Radiotherapy of ... Neoadjuvant chemoradiotherapy does not offer greater survival for stage IIIA/N2 non-small-cell lung cancer patients than ... "Patients with higher operative and surgical risks might be ideal candidates for bimodal therapy without surgery, whereas those ...http://oncologypro.esmo.org/Topics/Surgery-and-or-Radiotherapy-of-Cancer/Radiation-No-Extra-Benefit-To-Stage-IIIA-N2-NSCLC-Neoadjuvant-Chemotherapy
Neoadjuvant Treatment With Single-Agent Cetuximab Followed by 5-FU, Cetuximab, and Pelvic Radiotherapy: A Phase II Study in...
Thirty-five pts completed neoadjuvant treatment; 5 (12%) withdrew therapy after one cetuximab administration: three for ... 62 RADIOLOGY AND NUCLEAR MEDICINE; BIOPSY; CARCINOMAS; COMBINED THERAPY; INFUSION; PATIENTS; RADIATION DOSES; RADIOTHERAPY; ... Title: Neoadjuvant Treatment With Single-Agent Cetuximab Followed by 5-FU, Cetuximab, and Pelvic Radiotherapy: A Phase II Study ... Journal Article: Neoadjuvant Treatment With Single-Agent Cetuximab Followed by 5-FU, Cetuximab, and Pelvic Radiotherapy: A ...https://www.osti.gov/scitech/biblio/21172589
Neoadjuvant therapy - Wikipedia
Neoadjuvant therapy is the administration of therapeutic agents before a main treatment. One example is neoadjuvant hormone ... This systemic therapy (chemotherapy, immunotherapy or hormone therapy) or radiation therapy is commonly used in cancers that ... Neoadjuvant therapy aims to reduce the size or extent of the cancer before using radical treatment intervention, thus making ... By administering therapy a distinction can often be made. Some doctors give the therapy in the hope that a response will be ...https://en.wikipedia.org/wiki/Neoadjuvant_therapy
Neoadjuvant therapy for patients with HER2-positive breast cancer
General principles of neoadjuvant chemotherapy, including patient selection for neoadjuvant therapy, assessment of response to ... See 'Adjuvant systemic therapy for HER2-positive breast cancer', section on 'Patients who were treated with neoadjuvant therapy ... to neoadjuvant chemotherapy (NACT), even in the absence of HER2-targeted therapy [1,2]. Using targeted therapy to block ... Neoadjuvant therapy for patients with HER2-positive breast cancer. Author. William M Sikov, MD, FACP. William M Sikov, MD, FACP ...http://www.uptodate.com/contents/neoadjuvant-therapy-for-patients-with-her2-positive-breast-cancer
Neoadjuvant Therapy Redundantises Radiation -- MEDICA Trade Fair
... when they receive neoadjuvant chemotherapy before a mastectomy, according to researchers. ... Early-stage breast cancer patients who exhibit limited lymph node involvement may not require post-surgery radiation therapy ( ... Neoadjuvant Therapy Redundantises Radiation. "Radiation after surgery has been shown to benefit the survival of patients who ... "Our findings indicate neoadjuvant chemotherapy controlled the cancer and radiation would have been unnecessary for patients ...https://www.medica-tradefair.com/cgi-bin/md_medica/lib/pub/tt.cgi/Neoadjuvant_Therapy_Redundantises_Radiation.html?oid=25775&lang=2&ticket=g_u_e_s_t
Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer - Tabular View - ClinicalTrials.gov
Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer. Official Title ICMJE Neoadjuvant Therapy With Herceptin and ... Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer. This study has been completed. ... To examine the safety of Herceptin and Taxol therapy followed by surgery and chemotherapy [ Time Frame: 3 years ] ... After Herceptin and Taxol therapy, tumor assessment will be performed along with an echocardiogram and mammogram. ...https://clinicaltrials.gov/ct2/show/record/NCT00136539
Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1 - Full Text View - ClinicalTrials.gov
Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1 (NeoTRIPaPDL1). The safety and scientific validity of this ... Definite surgery will be performed not later than 6 weeks after the last dose of neoadjuvant therapy. Four cycles of AC or EC ... Definite surgery will be performed not later than 6 weeks after the last dose of neoadjuvant therapy. Four cycles of AC or EC ... Assess the clinical response rate after neoadjuvant therapy. *Distant Event Free Survival (DEFS) [ Time Frame: 5 years after ...https://clinicaltrials.gov/ct2/show/NCT02620280
Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer
The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma. Ther Adv Urol. 2016;8(2):130-41. [ ... Neoadjuvant therapy in differentiated thyroid cancer. Int J Surg Oncol. 2016;2016:3743420. [ Links ] ... B) Post-therapy whole-body scan revealing radioiodine-avid cervical lesions and pulmonary nodules. (C) Concomitant post-therapy ... Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma. J Clin Oncol. 2010;28(9): ...http://www.scielo.br/scielo.php?lng=en&script=sci_arttext&pid=S2359-39972018000300370
Nonanthracycline Combination Shows Promise as Neoadjuvant Therapy for Breast Cancer | Cancer Network | The Oncology Journal
MIAMI-As neoadjuvant therapy for breast cancer, docetaxel (Taxotere) plus cisplatin delivers pathologic complete response rates ... MIAMI As neoadjuvant therapy for breast cancer, docetaxel (Taxotere) plus. cisplatin delivers pathologic complete response ... therapy. Women who were estrogen receptor-positive (20 of 56 evaluable. patients, or 36%) received 20 mg tamoxifen daily. ... Pathologic complete response in the breast to neoadjuvant treatment was seen. in 15 of 56 evaluable patients (27%); 11 patients ...http://www.cancernetwork.com/articles/nonanthracycline-combination-shows-promise-neoadjuvant-therapy-breast-cancer
Taxanes in Adjuvant and Neoadjuvant Therapies for Breast Cancer | Cancer Network | The Oncology Journal
Taxanes as Neoadjuvant Therapy. The administration of neoadjuvant chemotherapy to patients with breast cancer has been the ... Neoadjuvant therapy may treat micrometastases before removal of the primary tumor can stimulate their growth. Neoadjuvant ... Paclitaxel as Neoadjuvant Therapy. The Buzdar Trial. Although most trials of paclitaxel in early stage breast cancer have ... A substantially lower incidence of neutropenia was observed in a small pilot trial of neoadjuvant therapy using the same ...http://www.cancernetwork.com/review-article/taxanes-adjuvant-and-neoadjuvant-therapies-breast-cancer
NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial)
... Mark van Heijl,. 1 Jikke MT Omloo,1 Mark I ... Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET. Best Pract Res Clin Gastroenterol. 2006;20:941-957. doi ... Brucher BL, Weber W, Bauer M, Fink U, Avril N, Stein HJ, Werner M, Zimmerman F, Siewert JR, Schwaiger M. Neoadjuvant therapy of ... NEOPEC: NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer; CT: computed tomography; FDG: 18F-fluoro- ...http://pubmedcentralcanada.ca/pmcc/articles/PMC3301128/
Pathological Complete Response After Neoadjuvant Therapy for Rectal Cancer and the Role of Adjuvant Therapy.
Both the addition of neoadjuvant chemoradiation therapy and improvements in surgical techniques have improved local control and ... Both the addition of neoadjuvant chemoradiation therapy and improvements in surgical techniques have improved local control and ... Indeed, the patients most consistently shown to benefit from adjuvant therapy both in terms of disease free survival (DFS) and ... Tumors that have high expression of thymidylate synthetase have also shown to benefit from adjuvant therapy. More study is ...http://www.biomedsearch.com/nih/Pathological-Complete-Response-After-Neoadjuvant/23381584.html
Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma
A Pilot and Phase II Study of Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III ... A Pilot and Phase II Study of Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III ... The proposed protocol aims to continue tumor-directed therapy during the typical "break. period" in an effort to improve on ... the 9-11 week period, thus allowing continuation of therapies directed towards both the. primary as well as distant sites of ...http://www.knowcancer.com/cancer-trials/NCT01302613/
Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a...
Knight G, Earle CC, Cosby R, et al.: Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and ... Li W, Qin J, Sun YH, Liu TS: Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis. World J Gastroenterol 2010 ... Adjuvant therapy. Among the 52 individuals treated with adjuvant chemoradiotherapy, 40 completed treatment (76.9%). Regarding ... All the patients were treated in 6 Mev Linear Accelerator with three-dimensional conformal therapy. Four fields (antero- ...http://ro-journal.biomedcentral.com.preview-live.oscarjournals.springer.com/articles/10.1186/1748-717X-7-169
Z Zoledronsäure - Oncoletter, Webportal für Onkologie und onkologische Hämatologie mit integrierten Links zu Wikipedia und...
Myeloma: Therapy, excluding Transplantation: Upfront Therapy for Multiple Myeloma: Induction and Maintenance ... SAKK 16/14 - Anti-PD-L1 antibody durvalumab (MEDI4736) in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) ... Myeloma: Therapy, excluding Transplantation: Upfront Therapy for Multiple Myeloma: Induction and Maintenance ... Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Therapies for Elderly Patients with AML ...http://www.oncoletter.ch/zoledronate.html